• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent.

作者信息

Hudson E A, Tisdale M J

机构信息

CRC Nutritional Biochemistry Research Group, Aston University, Birmingham, UK.

出版信息

Prostaglandins Leukot Essent Fatty Acids. 1994 Aug;51(2):141-5. doi: 10.1016/0952-3278(94)90090-6.

DOI:10.1016/0952-3278(94)90090-6
PMID:7972268
Abstract

A comparison has been made of the effectiveness of eicosapentaenoic (EPA) acid administered as either the free acid or the ethyl ester as an anticachectic and antitumour agent in mice bearing an experimental cachexia-inducing tumour (MAC16 colon adenocarcinoma). While the free acid of EPA was effective in reversing host body weight loss and inhibiting tumour growth the ethyl ester was ineffective in either respect at the same dose level, even when administered with a high fat diet. The lack of effectiveness of the ethyl ester correlated with the inability to reach effective plasma and tumour concentrations of EPA over the initial time period. Whereas effective plasma concentrations of EPA were achieved within 24 h after administration of the free acid, a time lapse of 96 h was required with the ethyl ester, even when combined with a high fat diet. Due to the acuteness of the MAC16 model this time is too long for a therapeutic benefit to be realized.

摘要

相似文献

1
Comparison of the effectiveness of eicosapentaenoic acid administered as either the free acid or ethyl ester as an anticachectic and antitumour agent.
Prostaglandins Leukot Essent Fatty Acids. 1994 Aug;51(2):141-5. doi: 10.1016/0952-3278(94)90090-6.
2
Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs.n-3脂肪酸对细胞毒性药物抗肿瘤作用的影响。
In Vivo. 2004 Sep-Oct;18(5):543-7.
3
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.二十碳五烯酸的抗恶病质和抗肿瘤作用及其对蛋白质周转的影响。
Cancer Res. 1991 Nov 15;51(22):6089-93.
4
Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid.二十碳五烯酸对小鼠肿瘤生长的抑制动力学——亚油酸的逆转作用
Biochem Pharmacol. 1993 Jun 9;45(11):2189-94. doi: 10.1016/0006-2952(93)90188-3.
5
Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid.二十碳五烯酸对体外肿瘤诱导的脂肪分解以及体内恶病质和肿瘤生长的抑制作用。
Biochem Pharmacol. 1991 Jan 1;41(1):103-7. doi: 10.1016/0006-2952(91)90016-x.
6
Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.二十碳五烯酸对癌症恶病质中脂肪分解和肌肉蛋白质降解的抑制作用。
Nutrition. 1996 Jan;12(1 Suppl):S31-3. doi: 10.1016/0899-9007(96)90015-5.
7
Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.二十碳五烯酸减轻癌症恶病质中骨骼肌蛋白分解代谢的机制
Cancer Res. 2001 May 1;61(9):3604-9.
8
Anticachectic activity of 5'-deoxy-5-fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma.5'-脱氧-5-氟尿苷在小鼠肿瘤恶病质模型(结肠26腺癌)中的抗恶病质活性
Cancer Res. 1990 Aug 1;50(15):4528-32.
9
5'-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice.5'-脱氧-5-氟尿苷通过一种独立于其在荷结肠26腺癌小鼠中的抗增殖作用的机制改善恶病质。
Cancer Chemother Pharmacol. 1991;29(1):1-6. doi: 10.1007/BF00686327.
10
Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.氟尿嘧啶对小鼠恶病质模型中恶病质和肿瘤生长的影响:与蛋白水解诱导因子的关系。
Br J Cancer. 2000 Jul;83(1):56-62. doi: 10.1054/bjoc.2000.1278.

引用本文的文献

1
Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models.癌症恶病质的营养干预:来自实验模型的证据与观点
Front Nutr. 2020 Dec 22;7:601329. doi: 10.3389/fnut.2020.601329. eCollection 2020.
2
Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1.索拉非尼和二十二碳六烯酸协同抑制癌细胞活力:血红素加氧酶 1 的作用。
BMC Cancer. 2018 Oct 26;18(1):1042. doi: 10.1186/s12885-018-4946-9.
3
Diet composition as a source of variation in experimental animal models of cancer cachexia.
饮食组成作为癌症恶病质实验动物模型中变异的一个来源。
J Cachexia Sarcopenia Muscle. 2016 May;7(2):110-25. doi: 10.1002/jcsm.12058. Epub 2015 Oct 15.
4
Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.高纯度的二十碳五烯酸以游离脂肪酸的形式强烈抑制 Apc(Min/+) 小鼠的息肉生长。
Clin Cancer Res. 2010 Dec 1;16(23):5703-11. doi: 10.1158/1078-0432.CCR-10-1990. Epub 2010 Oct 28.
5
Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells.PPAR-γ和p53参与二十二碳六烯酸诱导的Reh细胞凋亡。
Mol Cell Biochem. 2007 Oct;304(1-2):71-7. doi: 10.1007/s11010-007-9487-5. Epub 2007 May 9.
6
Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.二十碳五烯酸(EPA,一种来自鱼油的ω-3脂肪酸)用于治疗癌症恶病质。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004597. doi: 10.1002/14651858.CD004597.pub2.
7
Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas.二十碳五烯酸(EPA)可减少有结肠直肠腺瘤病史受试者正常结肠黏膜中的隐窝细胞增殖并增加细胞凋亡。
Int J Colorectal Dis. 2007 Jul;22(7):765-76. doi: 10.1007/s00384-006-0240-4. Epub 2007 Jan 10.